Evadapa 10 Tablet contains Dapagliflozin 10mg, an oral medication primarily used to manage type 2 diabetes mellitus. It belongs to the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, which work by preventing the kidneys from reabsorbing glucose back into the blood, thereby promoting its excretion through urine and effectively lowering blood sugar levels. Evadapa 10 is prescribed as part of a comprehensive diabetes management plan that includes diet, exercise, and possibly other antidiabetic medications. By reducing blood glucose, it helps in minimizing the risk of diabetes-related complications such as neuropathy, nephropathy, and cardiovascular diseases. Additionally, Dapagliflozin has shown benefits in improving heart failure outcomes and protecting kidney function in certain patient populations. It is generally well-tolerated, but users should be aware of potential side effects including urinary tract infections, genital infections, dehydration, and low blood pressure. Patients with severe kidney impairment or type 1 diabetes should avoid this medication. Regular monitoring of blood glucose, kidney function, and overall health is recommended while using Evadapa 10. Always consult a healthcare professional before starting or adjusting the dosage to ensure safe and effective use tailored to individual health needs.